Worth reading
50Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
706700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
706,700 shares exercised since the previous disclosure. The total number of shares delivered during the month was 706,700.
発行済株式総数
1.3% (the exercise ratio subject to exercise restrictions relative to the 53,641,000 shares delivered across all series)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price during the month under review was ¥72 or ¥70. Details of the adjustment clause and the floor price are Not disclosed.
Number of Stock Acquisition Rights
The total number issued is Not disclosed. The number of unexercised rights was 22,126 as of the previous disclosure and 15,059 as of the current date.
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Rules for Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financing
Timing 13 January 2026 / Type 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 706,700 shares exercised since the previous disclosure. The total number of shares delivered during the month was 706,700. |
| Dilution Rate | 1.3% (the exercise ratio subject to exercise restrictions relative to the 53,641,000 shares delivered across all series) |
| Total number of issued shares | 58,428,400 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | The exercise price during the month under review was ¥72 or ¥70. Details of the adjustment clause and the floor price are Not disclosed. |
| Number of Stock Acquisition Rights | The total number issued is Not disclosed. The number of unexercised rights was 22,126 as of the previous disclosure and 15,059 as of the current date. |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Rules for Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters. |
| Most recent equity financing | Timing 13 January 2026 / Type 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 13th Series Stock Acquisition Rights for August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.